Skip to content

Site logo

Main menu
  • Company
    • Company overview
    • Stories
    • History
    • Environmental, Social & Governance (ESG)
      • ESG overview
      • Philanthropy
      • Merck Medical Outreach Program
      • Impact investing
      • Transparency disclosures
      • ESG resources
    • Leadership
      • Leadership overview
      • Board of directors
      • Executive team
    • Culture & values
      • Culture & values overview
      • Code of conduct & compliance
    • Diversity & inclusion
    • Policies & positions
    • Business development & licensing
    • Suppliers
      • Suppliers overview
      • Supplier registration
      • Supplier help for Ariba
  • Research
    • Research overview
    • Areas of focus
      • Oncology
      • Vaccines
      • Infectious diseases
      • Cardio-metabolic disorders
    • Pipeline
    • Discovery & development
    • R&D locations
    • Clinical trials
      • Clinical trials overview
      • Find a trial
      • Diversity in clinical trials
  • Products
    • Products list
    • Safety data sheets
    • Product patents
    • Merck authorized distributors
  • Patients
    • Patients overview
    • Patient support programs
    • Patient resources
    • Patient & treatment education
  • Careers
    • Careers
    • Search jobs
    • Our divisions
      • Research & development
      • Manufacturing & supply
      • Human Health
      • Animal Health
      • Global support functions
    • Veterans
    • Student opportunities
    • Compensation & benefits
    • How we hire
    • MSD Careers
    • Events
    • Talent community
  • Investors
    • Investors overview
    • Events & presentations
    • Financial information
      • Financial information overview
      • SEC filings
    • Stock information
    • Investor resources
      • Investor resources overview
      • Organon resources
      • Request for information
  • Media
    • Media overview
    • News releases
    • Company statements
    • Media library & contacts
    • Company fact sheet
two scientists wearing masks

Our COVID-19 efforts

Learn more
Contact us

Worldwide Countries outside of the United States and Canada.

What can we help you find?

Search for:
Environmental, Social & Governance

Inspiring innovation through diversity and inclusion

When we bring together people from different backgrounds, the possibility for invention is endless

July 13, 2021

Share this article

article hero thumbnail

A diverse and inclusive workforce inspires innovation and is fundamental to our company’s success. Having an environment comprised of people from different dimensions of diversity also helps us better understand the unique needs of the customers, health care providers and patients we serve, including those with different abilities.

Below are some of the ways we celebrate our diverse workforce and a culture of equity, empowerment, engagement and belonging:

01.

Hiring neurodivergent talent

Our company and Accenture share a deep commitment to building a diverse workforce. Accenture is a Fortune Global 500 company with leading capabilities in digital, cloud and security where diversity and inclusion is at the core of their mission.

To support this shared commitment, Merck and Accenture launched a joint program called capABILITY in Action to hire neurodivergent talent and are partnering with Rangam Consultants Inc., a global workforce solutions company. Rangam is a diverse, minority women-owned business known for being a welcoming place for people with disabilities to work. The company is also certified by Disability:IN as a Disability Owned Business Enterprise (DOBE). Rangam’s SourceAbled program leverages their disability subject matter expertise and network to attract, recruit and retain neurodivergent talent while ensuring that we bring our recruits into an inclusive and supportive environment.

As part of the initial launch, autism awareness training was made available to employees about how to foster an engaging and inclusive environment for people who are autistic. 

“I was very surprised how kind and compassionate everyone at Rangam, Accenture and Merck is. It has been a very positive experience so far.”

Jila Naraghi
Rangam SourceAbled team member and new hire for Accenture at Merck

02.

Supplier diversity

Just as equal opportunity employment is central to our company’s personnel policies and procedures, we recognize that supplier diversity creates a competitive advantage for our company and positively impacts the global community.

In July 2021, our company was recognized as the top corporation for disability-owned businesses by Disability:IN for our supplier diversity program. This award honors the corporation that has demonstrated outstanding inclusion of Disability:IN certified disability-owned businesses (including businesses owned by service-disabled veterans), and general commitment to disability business inclusion within their supply chain processes and corporate supplier diversity programs.

Established in 1985, Merck’s supplier diversity program’s mission is to educate, equip and empower employees to effectively include and utilize qualified diverse suppliers in our global procurement activities at a competitive price while driving growth and innovation.

Additionally, in March 2021, our company partnered with Drexel University on the inaugural cohort of the newly launched “Merck Drexel Advanced Leadership Program for Diverse Suppliers (Merck Drexel ALP)”. Learn more about this program.

“We believe that the success of the company – and society – depends on enabling diverse businesses to share and grow in the global market.”

Susanna Webber, senior vice-president and chief procurement officer

03.

Global diversity & inclusion (GD&I) month

Since 2015, we’ve celebrated GD&I Experience Month in September to foster meaningful discussions and learning around diversity, equity and inclusion, while highlighting D&I-focused work and the people who make our company unique. GD&I Experience Month drives the company’s business performance, builds diversity and inclusion capabilities among the workforce and creates a platform for employees to speak up about their experiences.

Celeste Warren

“We have strengthened our commitment to making diversity and inclusion (D&I) a central strategy to business growth. Through these efforts, a clear purpose has emerged: to compel a more globally diverse and more inclusive workforce for our employees by creating an environment of belonging, engagement, equity and empowerment so that together, we can help ensure better health outcomes for patients.”

Celeste Warren
Vice president, diversity & inclusion center of excellence

04.

Employee Business Resource Groups (EBRGs)

We’ve taken a pioneering and global approach to our diversity strategy through the creation of Employee Business Resource Groups (EBRGs). With more than 19,000 members across 10 groups, EBRGs play a critical role in driving an inclusive culture and supporting employee career growth. They represent diversity within our company, and reflect the communities in which we live and serve.

  • Alianza
  • Asia Pacific Association
  • capAbility Network
  • Interfaith Organization
  • League of Employees of African Descent
  • Native American & Global Indigenous People
  • Next Gen Network
  • Rainbow Alliance
  • Veterans Leadership Network
  • Women’s Network
Marcos Roberto da Costa headshot

“I’m proud of our long-standing commitment to diversity, equity and inclusion. It has made us a more innovative and agile company – one that is better attuned to the needs of our employees, patients and customers.”

Marcos Roberto da Costa
Vice president, operational excellence, MMD and executive sponsor for Merck’s capABILITY network EBRG

Discover more stories

Safeguarding the environment through green chemistry

One scientist’s commitment to dengue fever research

Collaborating to help make cancer care more accessible worldwide

View all stories

Explore more in

Diversity and inclusion
Our people
Workplace

Connect with us on social

social icon social icon social icon social icon social icon
  • MerckHelps
    Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients
  • Merck Access Program
    Information about insurance coverage and financial assistance options for eligible patients
  • Clinical trials
    Learn about our clinical trials and find available studies
  • Merck Manuals
    Medical information source covering thousands of topics in all fields of medicine
  • Environmental, Social & Governance (ESG) Report
    Reporting on our commitment to operating responsibly to benefit society
  • Merck for Mothers
    An initiative to create a world where no woman has to die giving life
  • Merck Animal Health
    The global animal health business unit of Merck
  • Health Plan - Transparency in Coverage
    In compliance with the Consolidated Appropriations Act, learn more about our health plan's pricing information.
  • Forward-looking statement
  • Cookie policy
  • Privacy
  • Transparency disclosure
  • Terms of use
  • Accessibility
  • Sitemap
Copyright © 2023 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
Accessibility icon View Privacy Shield Verification Status View APEC CBPR Privacy Certification Status

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue